Exicure Depreciation & Amortization 2011-2026 | XCUR

Annual Depreciation & Amortization Exicure

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
242 K	28 K	634 K	1.16 M	1.12 M	766 K	392 K	358 K	232 K	180 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.16 M	28 K	512 K

Quarterly Depreciation & Amortization Exicure

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	61 K	-	-	-	7 K	-	-	-	251 K	-	289 K	291 K	302 K	-	283 K	283 K	263 K	-	159 K	187 K	148 K	-	91 K	87 K	87 K	-	90 K	90 K	86 K	-	70 K	51 K	38 K	-	46 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
302 K	7 K	148 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Anika Therapeutics ANIK	6.43 M	$ 14.93	0.88 %	$ 219 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.93	0.51 %	$ 5.07 M	China
Aquestive Therapeutics AQST	548 K	$ 4.14	0.36 %	$ 443 M	USA
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.39	4.5 %	$ 230 M	Israel
Ardelyx ARDX	3.06 M	$ 6.06	1.94 %	$ 1.46 B	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.93	1.27 %	$ 3.04 B	USA
Arvinas ARVN	3 M	$ 11.36	4.7 %	$ 805 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Arrowhead Pharmaceuticals ARWR	22.2 M	$ 61.99	1.57 %	$ 8.29 B	USA
Assembly Biosciences ASMB	129 K	$ 29.09	0.28 %	$ 326 M	USA
Actinium Pharmaceuticals ATNM	173 K	$ 1.13	15.26 %	$ 35.3 M	USA
Atossa Therapeutics ATOS	16 K	$ 5.19	-3.36 %	$ 44.7 M	USA
Atara Biotherapeutics ATRA	2.12 M	$ 5.0	0.2 %	$ 62.7 M	USA
Aurinia Pharmaceuticals AUPH	19.4 M	$ 16.05	2.79 %	$ 2.16 B	Canada
Autolus Therapeutics plc AUTL	8.3 M	$ 1.41	-0.35 %	$ 375 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Axon Enterprise AXON	48.4 M	$ 411.97	-0.2 %	$ 31.2 B	USA
Aytu BioScience AYTU	5.38 M	$ 2.65	-1.12 %	$ 16.6 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
BioCardia BCDA	24 K	$ 1.18	-1.67 %	$ 7.87 M	USA
BioCryst Pharmaceuticals BCRX	1.25 M	$ 9.59	6.26 %	$ 1.98 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	1.25 K	$ 3.05	1.51 %	$ 260 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 9.46	-3.47 %	$ 612 M	USA
BioVie BIVI	229 K	$ 1.46	2.81 %	$ 2.16 M	USA
BioMarin Pharmaceutical BMRN	79.6 M	$ 56.04	0.96 %	$ 10.7 B	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
BioXcel Therapeutics BTAI	300 K	$ 1.18	-0.42 %	$ 14.4 M	USA